Search

everythinglearnresearchcommunity

for

Search:↓

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Ozone therapy might improve cancer treatment and reduce its side effects.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Young women with PCOS without additional risk factors may have normal heart function.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.